<DOC>
	<DOCNO>NCT01452997</DOCNO>
	<brief_summary>The purpose study evaluate two separate antiinflammatory product relief symptom suppression immunological inflammatory response follow mosquito bite . The investigator select ibuprofen gel NSAI formulation 0.05 % Clobetasone butyrate steroid cream appropriate physical match placebo product .</brief_summary>
	<brief_title>Evaluation Anti-inflammatories Reduction Bite Reactions</brief_title>
	<detailed_description />
	<mesh_term>Bites Stings</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Clobetasone butyrate</mesh_term>
	<criteria>18 65 year age ( inclusive ) . Caucasian ( white pale skin ) Good health determine medical history physical examination Females child bear potential must confirm pregnant study start agree become pregnant throughout duration study . History follow triad symptom follow previous mosquito bite : weal , flare , pruritus immediate reaction mosquito bite least past ( = mosquito bite sensitive stage III IV ) . Willingness attend study procedure designate interval . Willingness provide full consent study Abnormalities skin forearm ( include sunburn ) might interfere study result , determine investigator/clinician physical inspection . History clinically significant cardiovascular , pulmonary , hepatic , renal , gastrointestinal , haematological , endocrine , metabolic , disease deem clinically significant investigator / clinician Use prohibit therapy ( include cosmetic either forearm ) specify Section 6.3.3 Clinical Trial Protocol ( use systemic local antihistamine , steroid , NSAIDs within 2 week prior plan date first study procedure ) ; use medication consider influence outcome study . Any acute illness within 7 day prior plan date first study procedure might interfere study result ( determined investigator/clinician medical history ) . History malignancy within 5 year plan date first study procedure Neurological psychiatric disease , drug alcohol abuse would interfere subject 's completion protocol assignment . Participated research involve investigational drug within 3 month plan date first study procedure . History know anaphylactic hypersensitivity mosquito bite , bee wasp sting . History allergic reaction topical agent use study component . History allergy latex rubber material Women pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>mosquito</keyword>
	<keyword>allergy</keyword>
	<keyword>bite</keyword>
	<keyword>ant-inflammatory</keyword>
	<keyword>Aedes aegypti mosquito bite</keyword>
</DOC>